Vanda Pharmaceuticals (VNDA) EPS (Basic) (QoQ) (2010 - 2026)
Vanda Pharmaceuticals (VNDA) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.94% |
| Dec 31, 2025 | -526.71% |
| Sep 30, 2025 | 17.05% |
| Jun 30, 2025 | 8.55% |
| Mar 31, 2025 | -500.97% |
| Dec 31, 2024 | 8.58% |
| Sep 30, 2024 | -18.20% |
| Jun 30, 2024 | -8.11% |
| Mar 31, 2024 | -72.26% |
| Dec 31, 2023 | -1,849.45% |
| Sep 30, 2023 | -90.83% |
| Jun 30, 2023 | -54.14% |
| Mar 31, 2023 | -53.40% |
| Dec 31, 2022 | 110.82% |
| Sep 30, 2022 | 25.76% |
| Jun 30, 2022 | 139.78% |
| Mar 31, 2022 | -190.42% |
| Dec 31, 2021 | -8.14% |
| Sep 30, 2021 | -20.13% |
| Jun 30, 2021 | 10.72% |